President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
Yahoo Finance ·
At the end of last year, the cannabis industry was rocked by a significant change in the laws covering the drug. This, however, wasn't as momentous as it first seemed. Let's shine a grow light on how it will affect -- or not -- three prominent marijuana companies, Canada-based Canopy Growth ( CGC 2.71% ) and Tilray Brands ( TLRY 0.69% ) , and the U.S. multi-state operator (MSO) Green Thumb Industries ( GTBIF 0.83% ) . For those unfamiliar, the federal government sorts controlled substances into five so-called schedules. Schedule I is for substances considered the most dangerous and with the least medicinal value. Harmfulness declines, and utility rises as we descend through Schedules II to V. Last December, President Donald Trump issued an executive order directing the Drug Enforcement Administration (DEA) to reschedule pot from Schedule I to Schedule III. This past April, the move was enacted by acting Attorney General Todd Blanche. That was a great triumph for the marijuana business , and a boon to every weed consumer in this country.
AI 시장 분석
President Donald Trump's executive order has downgraded cannabis from a Schedule I to a Schedule III controlled substance. This move recognizes the medicinal value of cannabis and lowers its risk assessment, significantly resolving legal uncertainties for the industry. Investors are watching to see if this deregulation will lead to improved profitability and market share expansion for major companies such as Canopy Growth, Tilray, and Green Thumb.
상승 영향
- Cannabis — The reclassification to Schedule III reduces tax burdens and officially recognizes medicinal value, expected to significantly improve the operating environment for key companies like Canopy Growth and Tilray.
DYAX 전담 분석
The reclassification of cannabis marks a major regulatory shift that could fundamentally change the financial landscape for the industry. By moving to Schedule III, companies gain relief from restrictive tax codes like 280E, which previously hindered net income growth. This institutional validation is expected to attract more traditional capital and institutional investors into the sector.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 38% · Bearish (Short) 62%
321 participants
Related News
- ConocoPhillips to buy 42% stake in BP venture supporting redevelopment of Iraqi oil fields
- SpaceX Investors Rip $565 Billion Out Of Elon Musk's Hands
- Green reforms? Europe is facing its ultimate climate reckoning
- REGENXBIO stock dips on $100M equity offering
- At a glance: stocks gapping down premarket
- Sodexo secures Meta food services contract